In the home, the lab and the factory, electric fields control technologies such as Kindle displays, medical diagnostic tests ...
Maze Therapeutics (NASDAQ:MAZE) surged ~68% in the premarket on Thursday after announcing data from a Phase 1 trial for MZE782, an experimental therapy targeted at chronic kidney disease and a rare ...
U.S. stocks were higher, with the Nasdaq Composite gaining more than 100 points on Thursday. Shares of Maze Therapeutics, Inc. (NASDAQ:MAZE) rose sharply during Thursday's session after the company ...